A Phase 2 Trial of Erlotinib in Patients With Previously Treated Squamous Cell and Adenocarcinoma of the Esophagus
Cancer - United States
doi 10.1002/cncr.25602
Full Text
Open PDFAbstract
Available in full text
Date
November 8, 2010
Authors
Publisher
Wiley